Verona Pharma Plc's Revenue per employee grew on a trailing twelve month basis to , the productivity of Verona Pharma Plc's employees reached a new high of $ 2,805,987.
Within the Healthcare sector Employees of 33 other companies have achieved higher revenue per employee. While Verona Pharma Plc's total ranking has deteriorated compared to the previous quarter from 0 to 331. Verona Pharma Plc has 79 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VRNA Revenue per Employee	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Revenue Change	-	-	-	-	-
Sales per Employee (TTM) $	2,805,987	1,500,443	535,177	71,190	-
VRNA's Total Ranking	# 331	# 0	# 0	# 0	# 0
Seq. Revenue Change	35.25 %	108.04 %	551.76 %	-	-

VRNA Company Profile >> Back to VRNA Efficiency Comparisons >> Compare VRNA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 21
Healthcare Sector	# 34
Overall Market	# 331

Revenue per Employee Statistics
High	Average	Low
$ 2,805,987	$ 2,805,987	$ 2,805,987
(Jun 30 2025)

Financial Statements
Verona Pharma Plc's Revenue MRQ	$ 103 Millions	Visit VRNA's Income Statement
Verona Pharma Plc's Revenues TTM	$ 222 Millions	Visit VRNA's aggregate revenue growth
What are VRNA's Sales?		Visit VRNA's Sales by Segment

Other Ratios
Verona Pharma Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VRNA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VRNA's Competitors
Revenue per Employee for VRNA's Suppliers
Revenue per Employee for VRNA's Customers

You may also want to know
VRNA's Sales Growth Rates	VRNA's Pe Price to earnings ratio	VRNA's Receivables Turnover Ratio	VRNA's Stock Quote
VRNA's Net Income Growth Rates	VRNA's Ps Price to Sales ratio	VRNA's Sales per Employee	VRNA's Asset Turnover Ratio
VRNA's Net Margin	VRNA's Pb Price to Book ratio	VRNA's Financial Strength Ratios	VRNA's Dividend Payout Ratio

Date modified: 2026-07-07T14:08:26+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2025	Number of Employees Jun 30 2025
P3 Health Partners Inc	4,568,196.88	$ 1,461.823 Million	320
Anika Therapeutics Inc	4,294,952.38	$ 90.194 Million	21
Aytu Biopharma Inc	4,114,437.50	$ 65.831 Million	16
Community Health Systems Inc	4,079,354.84	$ 12,646.000 Million	3,100
Ligand Pharmaceuticals Incorporated	3,986,978.72	$ 187.388 Million	47
Xeris Biopharma Holdings Inc	3,785,000.00	$ 246.025 Million	65
Siga Technologies Inc	3,666,110.67	$ 179.639 Million	49
Illumina Inc	3,346,875.00	$ 4,284.000 Million	1,280
Keros Therapeutics Inc	3,230,102.56	$ 251.948 Million	78
Xoma Royalty Corporation	3,210,857.14	$ 44.952 Million	14
Ironwood Pharmaceuticals inc	3,085,190.00	$ 308.519 Million	100
Catalyst Pharmaceuticals Inc	3,068,675.82	$ 558.499 Million	182
Sarepta Therapeutics Inc	2,971,893.41	$ 2,481.531 Million	835
Verona Pharma Plc	2,805,987.34	$ 221.673 Million	79
Halozyme Therapeutics Inc	2,786,458.63	$ 1,178.672 Million	423
Amgen Inc	2,685,923.08	$ 34,917.000 Million	13,000
Harmony Biosciences Holdings inc	2,632,058.02	$ 771.193 Million	293
Innoviva Inc	2,333,616.35	$ 371.045 Million	159
Therapeuticsmd Inc	2,246,000.00	$ 2.246 Million	1
Assertio Holdings inc	2,209,377.36	$ 117.097 Million	53
United Therapeutics Corporation	2,198,428.57	$ 3,077.800 Million	1,400
Indivior Pharmaceuticals Inc	2,062,000.00	$ 2,062.000 Million	1,000
Cytomx Therapeutics Inc	2,044,927.54	$ 141.100 Million	69
Aurinia Pharmaceuticals Inc	2,032,117.19	$ 260.111 Million	128
Prestige Consumer Healthcare Inc	1,964,512.28	$ 1,119.772 Million	570
Exelixis Inc	1,944,206.63	$ 2,230.005 Million	1,147
Spero Therapeutics Inc	1,943,040.00	$ 48.576 Million	25
Ascendis Pharma A	1,792,479.00	$ 179.248 Million	100
Ptc Therapeutics inc	1,780,957.62	$ 1,764.929 Million	991
Gilead Sciences Inc	1,697,823.53	$ 28,863.000 Million	17,000

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.